A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

By Kolibianakis E.M.   Schultze-Mosgau A.   Schroer A.   van Steirteghem A.   Devroey P.   Diedrich K.   Griesinger G.  

Human Reproduction, Vol. 20, Iss. 10, 2005-10 ,pp. : 2887-2892

Oxford University Press

Access to resources Recommend Favorite

Serum inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial

By Babayof Rachel   Margalioth Ehud J.   Huleihel Mahmoud   Amash Alaa   Zylber-Haran Edit   Gal Michael   Brooks Baruch   Mimoni Tzvia   Eldar-Geva Talia  

Human Reproduction, Vol. 21, Iss. 5, 2006-05 ,pp. : 1260-1265

Oxford University Press

Access to resources Recommend Favorite

Reproductive outcome of fresh or frozen–thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support

By Imbar Tal   Kol Shahar   Lossos Francine   Bdolah Yuval   Hurwitz A.   Haimov-Kochman Ronit  

Human Reproduction, Vol. 27, Iss. 3, 2012-03 ,pp. : 753-759

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study

By Prapas N.  

Human Reproduction, Vol. 20, Iss. 6, 2005-06 ,pp. : 1516-1520

Oxford University Press

Access to resources Recommend Favorite

Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos

By Endo Toshiaki  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2548-2551

Oxford University Press

Access to resources Recommend Favorite